Medistim ASA (LON:0OCD)
London flag London · Delayed Price · Currency is GBP · Price in NOK
183.00
+1.00 (0.55%)
Mar 11, 2025, 8:08 AM BST

Medistim ASA Cash Flow Statement

Millions NOK. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 2020 2019 - 2015
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Net Income
103.83103.82113.9790.969.39
Upgrade
Depreciation & Amortization
21.2323.6623.2923.4316.25
Upgrade
Other Amortization
3.28---6.89
Upgrade
Other Operating Activities
13.225.6912.919.833.17
Upgrade
Change in Accounts Receivable
-27.35-33.02-11.154.7
Upgrade
Change in Inventory
--31.06-16.9215.25-22.6
Upgrade
Change in Accounts Payable
-0.6111.27-0.32-1.3
Upgrade
Change in Other Net Operating Assets
--16.892-0.57-2.38
Upgrade
Operating Cash Flow
141.56113.19113.49127.3774.13
Upgrade
Operating Cash Flow Growth
25.07%-0.27%-10.90%71.82%-7.77%
Upgrade
Capital Expenditures
--16.4-9.25-7.4-7.45
Upgrade
Sale (Purchase) of Intangibles
--13.33-11.85-4.08-3.19
Upgrade
Other Investing Activities
-24.69----
Upgrade
Investing Cash Flow
-24.69-29.73-21.1-11.49-10.64
Upgrade
Long-Term Debt Repaid
--8.71-7.31-12-9.68
Upgrade
Net Debt Issued (Repaid)
--8.71-7.31-12-9.68
Upgrade
Common Dividends Paid
--82.18-68.4-54.64-50.05
Upgrade
Other Financing Activities
-91.536.015.47.591.39
Upgrade
Financing Cash Flow
-91.53-84.88-70.3-59.05-58.35
Upgrade
Foreign Exchange Rate Adjustments
-2.651.070.76-
Upgrade
Miscellaneous Cash Flow Adjustments
-0----
Upgrade
Net Cash Flow
25.341.2323.1557.65.15
Upgrade
Free Cash Flow
141.5696.79104.24119.9766.68
Upgrade
Free Cash Flow Growth
46.26%-7.15%-13.11%79.91%-0.02%
Upgrade
Free Cash Flow Margin
25.16%18.57%21.44%28.71%18.72%
Upgrade
Free Cash Flow Per Share
7.735.295.706.573.66
Upgrade
Cash Income Tax Paid
-25.719.1713.3419.05
Upgrade
Levered Free Cash Flow
115.6764.7156.3998.9847.3
Upgrade
Unlevered Free Cash Flow
115.6764.8156.4799.0947.4
Upgrade
Change in Net Working Capital
-9.2411.2834-17.7824.78
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.